Cargando…

P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO

Detalles Bibliográficos
Autores principales:	Kostik, MM, Vasyakina, LI, Ponomarenko, VM, Chikova, IA, Minkin, AV, Kalashnikova, OV, Shvedovchenko, IV, Chasnyk, VG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952960/ http://dx.doi.org/10.1186/1546-0096-11-S1-A201

Ejemplares similares

PReS-FINAL-2233: Retrospective analysis of different treatment strategies in chronic non-bacterial osteomyelitis
por: Kostik, MM, et al.
Publicado: (2013)

PReS-FINAL-2154: The early predictors of fatal outcome of macrophage activation syndrome in pediatric rheumatic diseases
por: Kostik, MM, et al.
Publicado: (2013)

Choosing the right treatment for patients with a severe course of chronic non-bacterial osteomyelitis (CNO) - pamidronate or TNF-α blockade?
por: Morbach, H, et al.
Publicado: (2015)

CNO in the Universe
Publicado: (2002)

PW03-006 - IL-1-B inhibition in Schnitzler’s syndrome
por: De Koning, HD, et al.
Publicado: (2013)

Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2014)

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
por: Ramanan, A. V., et al.
Publicado: (2019)

Synthesis of CNO elements in standard BBN
por: Iocco, F, et al.
Publicado: (2006)

CNO production in the first generation stars
por: Ekström, S, et al.
Publicado: (2006)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Conference on CNO (Carbon, Nitrogen And Oxygen) in the Universe
Publicado: (2002)

The Borexino heritage: pp and CNO solar neutrinos
por: Pallavicini, Marco
Publicado: (2021)

Differences in disease activity in cryopyrin-associated periodic syndrome in mutation-positive and mutation-negative patients
por: Kostik, M, et al.
Publicado: (2015)

Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2015)

Anemia in children with JIA: is it really driven by hepcidin level, or by a set of factors of a chronic disease
por: Egorov, Andrey, et al.
Publicado: (2014)

Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO)
por: Hofmann, Sigrun R., et al.
Publicado: (2012)

New experiments for the breakout off the Hot-CNO cycle
por: Kubono, S, et al.
Publicado: (1997)

Does the Sun Shine by pp or CNO Fusion Reactions?
por: Bahcall, John N., et al.
Publicado: (2002)

Comparison of different treatment approaches in chronic non-bacterial osteomyelitis.
por: Kostik, M, et al.
Publicado: (2015)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

The Proceedings of a Special IAU Session on CNO Isotopes in Astrophysics
por: Audouze, Jean
Publicado: (1977)

Unifocal and multifocal chronic non-bacterial osteomyelitis (CNO) in children
por: Zanon, G, et al.
Publicado: (2011)

Multi-channel R-matrix analysis of CNO cycle reactions
por: Simpson, E, et al.
Publicado: (2006)

HLA-B*27 is associated with CNO in a European cohort
por: O’Leary, Daire, et al.
Publicado: (2023)

Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO)
por: Leerling, A. T., et al.
Publicado: (2023)

Case report: Sulfasalazine-induced hypersensitivity
por: Kuchinskaya, Ekaterina M., et al.
Publicado: (2023)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

The Neurological Safety of Epidural Pamidronate in Rats
por: Lee, Pyung Bok, et al.
Publicado: (2010)

Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)

Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015)

Therapy with pamidronate in children with osteogenesis imperfecta
por: Marginean, Otilia, et al.
Publicado: (2017)

New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO
por: Hedrich, Christian M., et al.
Publicado: (2020)

Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO)
por: Zhao, Dan Yongdong, et al.
Publicado: (2021)

The using of arthroscopy and synovial biopsy in chronic knee monoarthritis in children
por: Chicova, IA, et al.
Publicado: (2008)

High resolution study of the $^{18}Ne$ structure relevant to the hot-CNO cycle
por: Park, S H, et al.
Publicado: (1999)

The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)—a systematic review
por: Hofmann, Sigrun Ruth, et al.
Publicado: (2017)

Fort CnoX: Protecting Bacterial Proteins From Misfolding and Oxidative Damage
por: Dupuy, Emile, et al.
Publicado: (2021)

Pamidronate “zebra lines”: A treatment timeline
por: Loizidou, Avgi, et al.
Publicado: (2017)

Pamidronate Treatment of Osteonecrosis of the Hip in Young Male
por: Lo Gullo, A., et al.
Publicado: (2018)

Inhibition of growth and migration of cholangiocarcinoma cells by pamidronate
por: Buranrat, Benjaporn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t392p4ddhg57cl7iemhnqpudvf